
OncoC4 to Present Cesalatamig Trial Results in Phoenix
The company will share Phase 1/2 clinical trial findings on November 7, 2026, at a major cancer immunotherapy meeting.

The company will share Phase 1/2 clinical trial findings on November 7, 2026, at a major cancer immunotherapy meeting.
October 29, 2026
Elicio Therapeutics to Present Cancer Trial ResultsThe company will unveil Phase 2 data at the SITC Annual Meeting in Phoenix this November.
October 20, 2026
Terri Ouellette Promotes Breast Cancer ScreeningsThe advocate is encouraging Phoenix residents to prioritize mammograms throughout Breast Cancer Awareness Month.
October 5, 2026
Medicenna Will Present MDNA11 Data in PhoenixMedicenna Therapeutics will share trial data on MDNA11 at the SITC 2026 Annual Meeting on November 7.
October 2, 2026
Agenus Will Present Cancer Research in PhoenixThe company will share clinical and translational data at the upcoming SITC 2026 Annual Meeting in November.
September 27, 2026
Phoenix Hosted 13th Annual Race Against CancerRunners gathered in downtown Phoenix to raise funds for cancer research and treatment at Chase Field.